Accendra Health Statistics
Total Valuation
Accendra Health has a market cap or net worth of $183.97 million. The enterprise value is $2.39 billion.
Important Dates
The next confirmed earnings date is Thursday, February 19, 2026, after market close.
| Earnings Date | Feb 19, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Accendra Health has 77.30 million shares outstanding. The number of shares has increased by 0.71% in one year.
| Current Share Class | 77.30M |
| Shares Outstanding | 77.30M |
| Shares Change (YoY) | +0.71% |
| Shares Change (QoQ) | +0.46% |
| Owned by Insiders (%) | 3.91% |
| Owned by Institutions (%) | 80.79% |
| Float | 61.11M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 2.88 |
| PS Ratio | 0.02 |
| Forward PS | 0.07 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.22 |
| EV / EBITDA | 4.73 |
| EV / EBIT | 8.74 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.86
| Current Ratio | 0.86 |
| Quick Ratio | 0.10 |
| Debt / Equity | n/a |
| Debt / EBITDA | 3.28 |
| Debt / FCF | n/a |
| Interest Coverage | 1.83 |
Financial Efficiency
Return on equity (ROE) is -196.39% and return on invested capital (ROIC) is 15.36%.
| Return on Equity (ROE) | -196.39% |
| Return on Assets (ROA) | 3.75% |
| Return on Invested Capital (ROIC) | 15.36% |
| Return on Capital Employed (ROCE) | 17.43% |
| Weighted Average Cost of Capital (WACC) | 5.76% |
| Revenue Per Employee | $464,175 |
| Profits Per Employee | -$57,777 |
| Employee Count | 23,200 |
| Asset Turnover | 2.36 |
| Inventory Turnover | 13.06 |
Taxes
In the past 12 months, Accendra Health has paid $13.56 million in taxes.
| Income Tax | 13.56M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -71.87% in the last 52 weeks. The beta is 1.34, so Accendra Health's price volatility has been higher than the market average.
| Beta (5Y) | 1.34 |
| 52-Week Price Change | -71.87% |
| 50-Day Moving Average | 2.50 |
| 200-Day Moving Average | 5.12 |
| Relative Strength Index (RSI) | 50.99 |
| Average Volume (20 Days) | 1,139,635 |
Short Selling Information
The latest short interest is 9.28 million, so 12.00% of the outstanding shares have been sold short.
| Short Interest | 9.28M |
| Short Previous Month | n/a |
| Short % of Shares Out | 12.00% |
| Short % of Float | 15.18% |
| Short Ratio (days to cover) | 4.49 |
Income Statement
In the last 12 months, Accendra Health had revenue of $10.77 billion and -$1.34 billion in losses. Loss per share was -$17.40.
| Revenue | 10.77B |
| Gross Profit | 2.24B |
| Operating Income | 273.75M |
| Pretax Income | -423.49M |
| Net Income | -1.34B |
| EBITDA | 506.59M |
| EBIT | 273.75M |
| Loss Per Share | -$17.40 |
Full Income StatementBalance Sheet
The company has $32.84 million in cash and $2.24 billion in debt, with a net cash position of -$2.21 billion or -$28.59 per share.
| Cash & Cash Equivalents | 32.84M |
| Total Debt | 2.24B |
| Net Cash | -2.21B |
| Net Cash Per Share | -$28.59 |
| Equity (Book Value) | -429.51M |
| Book Value Per Share | -5.56 |
| Working Capital | -334.29M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$98.98 million and capital expenditures -$240.66 million, giving a free cash flow of -$339.63 million.
| Operating Cash Flow | -98.98M |
| Capital Expenditures | -240.66M |
| Free Cash Flow | -339.63M |
| FCF Per Share | -$4.39 |
Full Cash Flow StatementMargins
Gross margin is 20.78%, with operating and profit margins of 2.54% and -12.45%.
| Gross Margin | 20.78% |
| Operating Margin | 2.54% |
| Pretax Margin | -3.93% |
| Profit Margin | -12.45% |
| EBITDA Margin | 4.70% |
| EBIT Margin | 2.54% |
| FCF Margin | n/a |
Dividends & Yields
Accendra Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.71% |
| Shareholder Yield | -0.71% |
| Earnings Yield | -728.61% |
| FCF Yield | -184.61% |
Analyst Forecast
The average price target for Accendra Health is $4.00, which is 68.07% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $4.00 |
| Price Target Difference | 68.07% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 1, 2010. It was a forward split with a ratio of 1.5:1.
| Last Split Date | Apr 1, 2010 |
| Split Type | Forward |
| Split Ratio | 1.5:1 |
Scores
Accendra Health has an Altman Z-Score of 2.54 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.54 |
| Piotroski F-Score | 3 |
